Company facts
- Industry
- Blank Checks
- Headquarters
- Los Angeles, California
- Most recent report
- 10-Q, filed Aug 12, 2026
- Filings on record
- 59 filings
- On EDGAR
- CIK 2029769
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 7
News 8
Prospectuses and Registrations 3
Proxies 1
Ownership 8 of 27
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 13, 2026
- SCHEDULE 13G Large holder reported a passive stake May 15, 2026
- SCHEDULE 13G Large holder reported a passive stake May 11, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 11, 2026
- 3 Insider reported their initial holding Oct 29, 2025
- 3 Insider reported their initial holding Oct 22, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2025
Other 8 of 13
- CERT Exchange certified a listing Oct 24, 2024
- EFFECT Notice that a registration became effective Oct 23, 2024
- 8-A12B Registration of a security for exchange listing Oct 23, 2024
- CORRESP Reply to SEC staff Oct 21, 2024
- CORRESP Reply to SEC staff Oct 21, 2024
- CORRESP Reply to SEC staff Oct 18, 2024
- UPLOAD Comment letter from SEC staff Oct 18, 2024
- CORRESP Reply to SEC staff Oct 4, 2024
Everything here comes from Oaktree Acquisition Corp. III Life Sciences's own filings on SEC EDGAR. The filing list is rechecked every hour.